Syneos Health: Partnering with Life Sciences Innovators in the United Kingdom
Biotechnology companies require an experienced, agile partner with deep therapeutic expertise and strategic insights to drive commercial performance while reaching full market potential.
With more than 30 years of experience working side by side with biotech companies – in nearly every therapeutic category and across all points along the asset development and commercialization continuum – Syneos Health is uniquely positioned to address ever-evolving biotech dynamics with relevant, efficient, custom solutions.
Our team is purpose built to leverage our vast experience, insights, capabilities and global infrastructure to deliver custom designed solutions, accessing the latest thinking surrounding clinical development, value, access, medical affairs, commercialization strategies and patient behavioral insights.
Proud to be a Member of OBN and BIA
Meet Our Experts
 Mark Miller-Holiday, Director, Business Development |  Helen Pappa, VP, Business Development |
 Noolie Gregory, VP, Decentralized Clinical Trials/Operations |  Bharat Chudasama VP, Syneos One |
Juliette Roberts, VP, Therapeutic Strategy and Innovation |
London, United Kingdom
10 Bloomsbury Way, 4th Floor
London WC1A 2SL
United Kingdom
Grow your career with a global company where the work you do matters everywhere.
Contact Us
Latest Insights
Want to learn more? Explore our Insights Hub.
2023 Health Trends from Syneos Health – Download the full report, get the podcast and more.
Implementing Decentralized Clinical Trials: Strategic Design Vs. “Retrofitting”
Syneos Health Podcast: Decentralized Clinical Trials: Implications for Biotech
Understanding the Role of the Placebo Response in Clinical Trials
Not All Decentralized Clinical Trial Capabilities Are Created Equal
WEBINAR: Accelerate Time to Target Endpoint Using Patient-Centered Technology Solutions
How Clarity Can Be a Differentiator for Biotechs in Uncertain Times
VIDEO: Fireside Chat on Product Commercialization in 2022
The Win-Win of End-to-End Outsourcing for Biopharma
